Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey
Rajabally YA. et al, (2025), Journal of the Peripheral Nervous System, 30
Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitis
Sun B. et al, (2025), Science Advances, 11
Inter-Laboratory Validation of Nodal/Paranodal Antibody Testing.
Lleixà C. et al, (2025), J Peripher Nerv Syst, 30
Electrodiagnostic subtyping in Guillain-Barré syndrome patients in the International Guillain-Barré Outcome Study.
Arends S. et al, (2024), Eur J Neurol, 31
Combined central and peripheral demyelination in two siblings, immune mediated or genetic?
Moodley K. et al, (2024), Pract Neurol
Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease.
Bellanti R. et al, (2023), J Neurol Neurosurg Psychiatry
Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.
Moodley K. et al, (2023), J Peripher Nerv Syst
Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation
Keddie S. et al, (2023), Brain
AL amyloidosis presenting with isolated lumbosacral radiculoplexus neuropathy
Bellanti R. et al, (2023), Practical Neurology
Peripherin is a biomarker of axonal damage in peripheral nervous system disease
Keddie S. et al, (2023), Brain
Utilising clinical parameters to improve the selection of nerve biopsy candidates
Kopanidis P. et al, (2023), Internal Medicine Journal